Usefulness of osteoprotegerin in assessing responses to ...

neridronate treatment in 9 patients with Paget’s disease of bone unresponsive to clodronate. Five months after ner-idronate treatment, we observed significant reductions in serum levels of AP and BAP (41.9% and 38.8%, respective-ly) compared to pretreatment values (Table 1). Serum levels of OPG, before and after treatment, were within normal lev- ................
................